Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Diabetes
Interventions
BIOLOGICAL

Glucagon

One hour glucagon-clamp followed by one hour of blood sampling

Trial Locations (1)

2900

Center for Diabetes Research, Department of Medicine, Gentofte Hospital, Hellerup

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

collaborator

European Foundation for the Study of Diabetes

OTHER

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT02475421 - Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon Clearance | Biotech Hunter | Biotech Hunter